Clinical trials by condition

Alpha-1-antitrypsin deficiency (AATD) clinical trials near you

13 studies for Alpha-1-antitrypsin deficiency (AATD) are recruiting volunteers at 67 research sites in 22 states.

Also called A1AT deficiency, AAT deficiency.

Part of Liver diseases

Studies recruiting
13
Research sites
67
States
22

What is Alpha-1-antitrypsin deficiency (AATD)?

Alpha-1 antitrypsin deficiency (AATD) is an inherited condition in which the body is short of a protein called alpha-1 antitrypsin (AAT). AAT is made in the liver and helps protect the lungs from inflammation and from irritants a person breathes in, such as smoke.

With too little AAT, tobacco smoke, dust and air pollution harm the lungs more easily and can lead to a serious lung disease called COPD. In some forms, the AAT has the wrong shape and gets stuck in the liver, harming it over time. AATD can cause liver disease, including cirrhosis, in babies, children and adults.

There is no cure, but treatment can ease symptoms and slow lung damage. It may include inhaled medicines, pulmonary rehabilitation, oxygen, and lifelong augmentation therapy, which raises AAT levels using the protein taken from donated blood. A lung or liver transplant may be needed if the damage is severe.

Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 13, 2026. Read more on MedlinePlus

Areas with the most Alpha-1-antitrypsin deficiency (AATD) studies

Metro areas where studies for Alpha-1-antitrypsin deficiency (AATD) are recruiting, each study counted once in an area.

  1. 1CharlestonSouth Carolina6 studies
  2. 2GainesvilleFlorida5 studies
  3. 3BirminghamAlabama4 studies
  4. 4BostonMassachusetts4 studies
  5. 5Los AngelesCalifornia4 studies
  6. 6MiamiFlorida4 studies
  7. 7New YorkNew York4 studies
  8. 8RochesterMinnesota4 studies
  9. 9PhoenixArizona3 studies
  10. 10Ann ArborMichigan2 studies

By state

Studies for Alpha-1-antitrypsin deficiency (AATD) recruiting in each state.

  • Florida9 studies · 9 sites
  • South Carolina6 studies · 4 sites
  • Alabama4 studies · 3 sites
  • California4 studies · 6 sites
  • Massachusetts4 studies · 3 sites
  • Minnesota4 studies · 3 sites
  • New York4 studies · 4 sites
  • Texas4 studies · 6 sites
  • Arizona3 studies · 6 sites
  • Colorado3 studies · 2 sites
All 22 states

Whom the studies accept

The share of the Alpha-1-antitrypsin deficiency (AATD) studies open to each group. A study can accept several.

  • Adults 18 to 64100%
  • Adults 65 and over100%
  • Children and teens (under 18)23%
  • Healthy volunteers23%
  • Open to all sexes100%

Study phases

Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.

  • Phase 115%
  • Phase 1/215%
  • Phase 323%
  • Not stated46%

Cite these figures

Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.

As text

Source: LocalTrial, Alpha-1-antitrypsin deficiency (AATD) clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/alpha-1-antitrypsin-deficiency, updated November 13, 2026.

With the link, for a web page

Source: <a href="https://www.localtrial.com/clinical-trials/conditions/alpha-1-antitrypsin-deficiency">LocalTrial, Alpha-1-antitrypsin deficiency (AATD) clinical trials near you</a>, updated November 13, 2026.

About these figures

Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study Alpha-1-antitrypsin deficiency (AATD). A study is counted once however many sites it has.

Updated November 13, 2026.

These figures describe studies, not advice. Talk to your doctor before joining one.

Tell us a little about yourself and we'll suggest the Alpha-1-antitrypsin deficiency (AATD) studies near you that may fit. Free and private.

Find Alpha-1-antitrypsin deficiency (AATD) studies near me
Alpha-1-antitrypsin deficiency (AATD) Clinical Trials Near Me | LocalTrial